These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30977089)

  • 21. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
    Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome.
    Nasri K; Hantoushzadeh S; Aghadavod E; Taghizadeh M; Asemi Z
    Horm Metab Res; 2017 Jun; 49(6):446-451. PubMed ID: 28235206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.
    Shokrpour M; Foroozanfard F; Afshar Ebrahimi F; Vahedpoor Z; Aghadavod E; Ghaderi A; Asemi Z
    Gynecol Endocrinol; 2019 May; 35(5):406-411. PubMed ID: 30608001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
    Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
    Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial.
    Afshar Ebrahimi F; Foroozanfard F; Aghadavod E; Bahmani F; Asemi Z
    Biol Trace Elem Res; 2018 Aug; 184(2):300-307. PubMed ID: 29127547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Samimi M; Zarezade Mehrizi M; Foroozanfard F; Akbari H; Jamilian M; Ahmadi S; Asemi Z
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):560-566. PubMed ID: 27911471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z
    Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial.
    Sangouni AA; Sasanfar B; Ghadiri-Anari A; Hosseinzadeh M
    Clin Nutr ESPEN; 2021 Dec; 46():54-59. PubMed ID: 34857248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of fish oil on gene expression in patients with polycystic ovary syndrome.
    Rahmani E; Jamilian M; Dadpour B; Nezami Z; Vahedpoor Z; Mahmoodi S; Aghadavod E; Taghizadeh M; Beiki Hassan A; Asemi Z
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29359480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M; Maktabi M; Asemi Z
    Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
    Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
    Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial.
    El Sharkwy I; Sharaf El-Din M
    Gynecol Endocrinol; 2019 Aug; 35(8):701-705. PubMed ID: 30806102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
    Hu X; Wang W; Su X; Peng H; Tan Z; Li Y; Huang Y
    PeerJ; 2023; 11():e16410. PubMed ID: 38025704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome.
    Khorshidi M; Moini A; Alipoor E; Rezvan N; Gorgani-Firuzjaee S; Yaseri M; Hosseinzadeh-Attar MJ
    Phytother Res; 2018 Nov; 32(11):2282-2289. PubMed ID: 30062709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian H; Jamilian M; Samimi M; Afshar Ebrahimi F; Rahimi M; Bahmani F; Aghababayan S; Kouhi M; Shahabbaspour S; Asemi Z
    Gynecol Endocrinol; 2017 Jun; 33(6):442-447. PubMed ID: 28277138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome.
    Farsinejad-Marj M; Azadbakht L; Mardanian F; Saneei P; Esmaillzadeh A
    Biol Trace Elem Res; 2020 Aug; 196(2):349-358. PubMed ID: 31960275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Heshmati J; Omani-Samani R; Vesali S; Maroufizadeh S; Rezaeinejad M; Razavi M; Sepidarkish M
    Horm Metab Res; 2018 Mar; 50(3):193-200. PubMed ID: 29523006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.